We fund research designed to find innovative ways to develop new drugs, barriers to the insects and worms that carry the parasites, diagnostics and other tools against infectious diseases in developing countries. We also look for new ways to distribute and increase access to these tools. Work led by researchers from disease endemic countries is always one of our top considerations.
Calls for grant applications or/and letters of interest
Call for expression of interest: Hosting of an online database platform for tuberculosis treatment clinical trial data
Deadline for submission: 15th February 2015
Grants currently underway or in review
Research on innovative approaches for safety monitoring in seasonal malaria chemoprevention
Deadline for submission: 23 December 2014
Research teams from African institutions are invited to submit Letters of Interest (LoI) for research on piloting innovative approaches for safety monitoring in the context of seasonal malaria chemoprevention. Under this call, one or two research teams are expected to be selected for funding for a maximum amount of US$ 75 000 each.
Complete information and application process (English)
Complete information and application process (French)
Joint EMRO/TDR small grants scheme for implementation research in infectious diseases of poverty
Deadline for submission: 20 January 2015
Only applicants from the WHO Eastern Mediterranean Region eligible.
This joint call with the Eastern Mediterranean Regional Office of the World Health Organization supports evidence generated from local research for the prevention and control of tropical diseases in the WHO Eastern Mediterranean Region (EMR) countries and takes into account the outcomes of the recent meeting in February 2014 at the regional office: “Integrating Research in Shaping The Future of Health in The EMR”. The call welcomes research which links communicable and tropical diseases of poverty in co-morbidity with non-communicable diseases.
Five calls for applications / letters of interest in collaboration for:Research on the vulnerability of preventive chemotherapy of helminth infections to emergence of drug resistance
Application deadlines vary from 31 August through 12 January 2015 (see PDF file below for complete details)
TDR is expanding support for research on key determinants of sustained effectiveness of preventive chemotherapy for schistosomiasis, soil transmitted helminths (STH), lymphatic filariasis and onchocerciasis: the probability, potential impact and detection of the emergence of resistance to the drugs used.
Planned research activities to be supported are grouped into two projects:
- Vulnerability of schistosomiasis, STH, onchocerciasis and lymphatic filariasis control to emergence of drug resistance and its consequences (TDResist, 3 calls, available funding: US$ 260 000)
- Integrated capacity building and research for ivermectin resistance surveillance and definition of O. volvulus transmission zones by onchocerciasis control programmes (CARIRS, 2 calls, available funding: US$ 400 000).
Research on the etiological causes of serious infections in young African infants
Deadline for submission: 25 August 2014
As part of TDR’s focus on improving maternal and childhood health, research teams from African research institutions were invited to submit Letters of Interest (LoI) to undertake a prospective study to investigate the aetiologies of serious infection in young infants in rural areas of Africa. We received 47 applications from 14 different African countries. The applications are being reviewed by an external scientific working group that will evaluate the applications submitted based on scientific merit, relevance to the call and feasibility. The review process is expected to be completed by end of October, when two research teams are expected to be selected for funding for a maximum amount of US$ 140 000 each.